Exscientia expands biologics design capability with automated laboratory

Oxford, england--(business wire)--exscientia plc (nasdaq: exai) today announced the expansion of its platform to include the design of biologics, such as human antibodies.

EXAI Ratings Summary

EXAI Quant Ranking